Shanghai, China

Jingyu Leng

This inventor holds 1 USPTO granted patent. Top assignee: Livzon Mabpharm Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingyu Leng. Retrieved from https://idiyas.com/inventor/jingyu-leng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jingyu Leng

Introduction

Jingyu Leng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work is recognized for its potential impact on medical treatments.

Latest Patents

Jingyu Leng holds a patent for a "Liquid Preparation Containing Anti-IL-17 Antibody." This innovation is aimed at addressing various inflammatory conditions, showcasing his commitment to advancing healthcare solutions. He has 1 patent to his name.

Career Highlights

Jingyu Leng is currently employed at Livzon Mabpharm Inc., a company known for its focus on biopharmaceuticals. His role involves research and development, where he applies his expertise to create effective medical treatments. His contributions have been instrumental in the company's growth and innovation.

Collaborations

Jingyu has collaborated with talented individuals such as Yi Lu and Denghui He. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Jingyu Leng's work exemplifies the spirit of innovation in biotechnology. His patent and collaborations highlight his dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…